vs

Side-by-side financial comparison of Custom Truck One Source, Inc. (CTOS) and Lantheus Holdings, Inc. (LNTH). Click either name above to swap in a different company.

Custom Truck One Source, Inc. is the larger business by last-quarter revenue ($422.2M vs $406.8M, roughly 1.0× Lantheus Holdings, Inc.). Lantheus Holdings, Inc. runs the higher net margin — 13.3% vs -4.2%, a 17.5% gap on every dollar of revenue. On growth, Lantheus Holdings, Inc. posted the faster year-over-year revenue change (4.0% vs -8.5%). Over the past eight quarters, Custom Truck One Source, Inc.'s revenue compounded faster (14.8% CAGR vs 4.9%).

Custom Truck One Source, Inc. is a leading provider of specialized heavy truck and equipment solutions in North America. It offers custom vehicle manufacturing, equipment sales and rentals, aftermarket parts, and maintenance services, serving core infrastructure, utility, construction, and energy industry segments.

Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.

CTOS vs LNTH — Head-to-Head

Bigger by revenue
CTOS
CTOS
1.0× larger
CTOS
$422.2M
$406.8M
LNTH
Growing faster (revenue YoY)
LNTH
LNTH
+12.5% gap
LNTH
4.0%
-8.5%
CTOS
Higher net margin
LNTH
LNTH
17.5% more per $
LNTH
13.3%
-4.2%
CTOS
Faster 2-yr revenue CAGR
CTOS
CTOS
Annualised
CTOS
14.8%
4.9%
LNTH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CTOS
CTOS
LNTH
LNTH
Revenue
$422.2M
$406.8M
Net Profit
$-17.8M
$54.1M
Gross Margin
20.3%
59.2%
Operating Margin
2.9%
19.0%
Net Margin
-4.2%
13.3%
Revenue YoY
-8.5%
4.0%
Net Profit YoY
-333.7%
558.8%
EPS (diluted)
$-0.08
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTOS
CTOS
LNTH
LNTH
Q1 26
$422.2M
Q4 25
$387.3M
$406.8M
Q3 25
$359.9M
$384.0M
Q2 25
$392.2M
$378.0M
Q1 25
$307.1M
$372.8M
Q4 24
$398.3M
$391.1M
Q3 24
$337.5M
$378.7M
Q2 24
$320.6M
$394.1M
Net Profit
CTOS
CTOS
LNTH
LNTH
Q1 26
$-17.8M
Q4 25
$20.9M
$54.1M
Q3 25
$-5.8M
$27.8M
Q2 25
$-28.4M
$78.8M
Q1 25
$-17.8M
$72.9M
Q4 24
$27.6M
$-11.8M
Q3 24
$-17.4M
$131.1M
Q2 24
$-24.5M
$62.1M
Gross Margin
CTOS
CTOS
LNTH
LNTH
Q1 26
20.3%
Q4 25
31.8%
59.2%
Q3 25
28.0%
57.9%
Q2 25
26.1%
63.8%
Q1 25
27.9%
63.8%
Q4 24
29.7%
63.5%
Q3 24
27.2%
63.9%
Q2 24
27.8%
64.9%
Operating Margin
CTOS
CTOS
LNTH
LNTH
Q1 26
2.9%
Q4 25
13.4%
19.0%
Q3 25
9.1%
11.4%
Q2 25
7.1%
23.3%
Q1 25
4.0%
27.4%
Q4 24
16.9%
29.1%
Q3 24
6.8%
35.3%
Q2 24
5.5%
26.1%
Net Margin
CTOS
CTOS
LNTH
LNTH
Q1 26
-4.2%
Q4 25
5.4%
13.3%
Q3 25
-1.6%
7.2%
Q2 25
-7.2%
20.8%
Q1 25
-5.8%
19.6%
Q4 24
6.9%
-3.0%
Q3 24
-5.2%
34.6%
Q2 24
-7.6%
15.8%
EPS (diluted)
CTOS
CTOS
LNTH
LNTH
Q1 26
$-0.08
Q4 25
$0.10
$0.86
Q3 25
$-0.03
$0.41
Q2 25
$-0.13
$1.12
Q1 25
$-0.08
$1.02
Q4 24
$0.11
$-0.18
Q3 24
$-0.07
$1.79
Q2 24
$-0.10
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOS
CTOS
LNTH
LNTH
Cash + ST InvestmentsLiquidity on hand
$6.3M
$359.1M
Total DebtLower is stronger
$25.9M
$568.7M
Stockholders' EquityBook value
$809.1M
$1.1B
Total Assets
$3.4B
$2.2B
Debt / EquityLower = less leverage
0.03×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOS
CTOS
LNTH
LNTH
Q1 26
$6.3M
Q4 25
$6.3M
$359.1M
Q3 25
$13.1M
$382.0M
Q2 25
$5.3M
$695.6M
Q1 25
$5.4M
$938.5M
Q4 24
$3.8M
$912.8M
Q3 24
$8.4M
$866.4M
Q2 24
$8.1M
$757.0M
Total Debt
CTOS
CTOS
LNTH
LNTH
Q1 26
$25.9M
Q4 25
$1.6B
$568.7M
Q3 25
$1.6B
$567.9M
Q2 25
$1.6B
$566.8M
Q1 25
$1.6B
$566.1M
Q4 24
$1.5B
$565.3M
Q3 24
$1.6B
$613.0K
Q2 24
$1.5B
$563.2M
Stockholders' Equity
CTOS
CTOS
LNTH
LNTH
Q1 26
$809.1M
Q4 25
$809.1M
$1.1B
Q3 25
$784.7M
$1.1B
Q2 25
$790.1M
$1.2B
Q1 25
$813.4M
$1.2B
Q4 24
$861.3M
$1.1B
Q3 24
$837.5M
$1.2B
Q2 24
$856.7M
$1.0B
Total Assets
CTOS
CTOS
LNTH
LNTH
Q1 26
$3.4B
Q4 25
$3.4B
$2.2B
Q3 25
$3.5B
$2.3B
Q2 25
$3.6B
$2.1B
Q1 25
$3.5B
$2.1B
Q4 24
$3.5B
$2.0B
Q3 24
$3.6B
$2.0B
Q2 24
$3.5B
$1.9B
Debt / Equity
CTOS
CTOS
LNTH
LNTH
Q1 26
0.03×
Q4 25
2.03×
0.52×
Q3 25
2.10×
0.51×
Q2 25
2.04×
0.49×
Q1 25
1.97×
0.49×
Q4 24
1.77×
0.52×
Q3 24
1.87×
0.00×
Q2 24
1.79×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOS
CTOS
LNTH
LNTH
Operating Cash FlowLast quarter
$90.2M
Free Cash FlowOCF − Capex
$81.4M
FCF MarginFCF / Revenue
20.0%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$354.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOS
CTOS
LNTH
LNTH
Q1 26
Q4 25
$47.3M
$90.2M
Q3 25
$81.5M
$105.3M
Q2 25
$125.7M
$87.1M
Q1 25
$55.6M
$107.6M
Q4 24
$82.1M
$157.7M
Q3 24
$16.5M
$175.1M
Q2 24
$37.8M
$84.7M
Free Cash Flow
CTOS
CTOS
LNTH
LNTH
Q1 26
Q4 25
$81.4M
Q3 25
$94.7M
Q2 25
$79.1M
Q1 25
$98.8M
Q4 24
$141.4M
Q3 24
$159.3M
Q2 24
$73.5M
FCF Margin
CTOS
CTOS
LNTH
LNTH
Q1 26
Q4 25
20.0%
Q3 25
24.7%
Q2 25
20.9%
Q1 25
26.5%
Q4 24
36.1%
Q3 24
42.0%
Q2 24
18.7%
Capex Intensity
CTOS
CTOS
LNTH
LNTH
Q1 26
Q4 25
2.2%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
2.3%
Q4 24
4.2%
Q3 24
4.2%
Q2 24
2.8%
Cash Conversion
CTOS
CTOS
LNTH
LNTH
Q1 26
Q4 25
2.27×
1.67×
Q3 25
3.79×
Q2 25
1.11×
Q1 25
1.47×
Q4 24
2.98×
Q3 24
1.34×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTOS
CTOS

Equipment sales$273.9M65%
Rental revenue$116.3M28%
Parts sales and services$32.1M8%

LNTH
LNTH

Radiopharmaceutical Oncology$240.2M59%
Definity$85.3M21%
Strategic Partnerships And Other$23.3M6%
Techne Lite$21.0M5%
Licenseand Royalty Revenues$17.4M4%
Other$13.6M3%
Other Precision Diagnostics$5.9M1%

Related Comparisons